Summarized by Masters of Longevity from Fight Aging!.
Reports a preclinical discovery that blocking a specific metabolic protein interaction selectively kills senescent cells and reduces their inflammatory secretions in animals.
Key Takeaways
- Researchers identified binding between phosphoglycerate mutase 1 and CHK1 as supporting increased glycolysis in senescent cells.
- Pharmacological inhibition of the PGAM1‑CHK1 interaction removed senescent cells and suppressed the senescence‑associated secretory phenotype in models.
- PGAM1‑CHK1 inhibition alleviated organ damage and reduced pulmonary fibrosis in vivo in the reported animal studies.
